Indexes as a Metric for Drug and Alcohol Policy Evaluation and Assessment

AuthorAlison Ritter,Vivienne L. Moxham‐Hall
DOIhttp://doi.org/10.1002/wmh3.218
Published date01 March 2017
Date01 March 2017
Indexes as a Metric for Drug and Alcohol Policy
Evaluation and Assessment
Vivienne L. Moxham-Hall and Alison Ritter
Indexes are measurement tools used to capture the multi-dimensionality of complex issues and have
been used increasingly in the contemporary evaluation of policies including in the drug and alcohol
f‌ield. This article systematically reviews all published alcohol and illicit drug indexes to date in
terms of their primary purpose, design and methodology, and application in practice. Twenty-four
unique indexes (across 61 papers) were found which f‌it the review criteria. When grouped on the
basis of output- or input-driven indicators, the indexes broadly fell into three categories: Harm
Indexes (output-driven), of which there were 10 and were primarily concerned with measuring the
consequences of illicit drug use; Policy Indexes (input-driven) of which there were seven and were
predominantly concerned with alcohol control policy measurement; and Treatment Need Indexes
(neither purely output or input-driven) of which there were also seven, which measured the extent
of treatment need across multiple substances. There was substantial methodological diversity in
terms of normalization, weighting, and aggregation methods. The f‌indings demonstrate silos in the
purpose, design, and use of indexes.
KEY WORDS: drug policy, alcohol control, index measurement
Introduction
Composite indicators, referred to here as indexes, have been used extensively
in research and policy making due to their ability to integrate complex
multidimensional concepts into a single comparable metric. The categorization of
widely different types of data into a single index facilitates a number of different
types of comparisons: comparisons over time (trends) within one place,
comparisons between two or more places, and comparisons between substances.
In policy evaluation, an index can be used as an outcome measure to compare
policy implementation, effectiveness, or enforcement, making it a valuable
research, political, and communication tool (Nardo & Saisana, 2008; OECD, 2008;
Saisana & Tarantola, 2002).
Indexes are already widely used across a number of different f‌ields. Some
examples of well-known indexes include the Human Development Index (HDI)
World Medical & Health Policy, Vol. 9, No. 1, 2017
103
1948-4682 #2017 Policy Studies Organization
Published by Wiley Periodicals, Inc., 350 Main Street, Malden, MA 02148, USA, and 9600 Garsington Road, Oxford, OX4 2DQ.
(UNDP, 2015), the Ecological Footprint (Borucke et al., 2013), and the Consumer
Price Index (CPI) (ILO et al., 2004). The HDI, developed by the United Nations
Development Program, is a well-recognized and highly utilized index that has
enabled the assessment of intercountry development levels through the integra-
tion of life expectancy and adult literacy variables. Changes in HDI values and
the subindexes within the HDI allow for the monitoring of changes in a country’s
development. The HDI also allows for the identif‌ication of “policy gaps” to direct
resources and national priorities and thus can stimulate national policy dis-
cussions. Some of the advantages and disadvantages of indexes have been
summarized well by Saisana and Tarantola (2002). Benef‌its of an index include its
ability to condense complex and multidimensional issues to support the decisions
of policy and program advisors, enable a “big picture” view of complicated
issues, facilitate rankings between jurisdictions, and attract public interest in
country performance and progress over time. However, drawbacks of indexes
include the number of subjective judgements that need to be made in their
construction (indicator selection, weighting, etc.), the ability to draw simplistic
policy conclusions from index values, the likelihood of poorly constructed or
poorly interpreted indexes sending misleading and nonrobust policy messages,
and the quantity of data needed to produce a statistically signif‌icant analysis
(Saisana & Tarantola, 2002). Further to this the conversion of all the complex
indicators into a single, summable f‌igure (or common metric) is fraught with
diff‌iculties, and the utility of such a measure has been questioned (Ritter, 2007;
Rolles & Measham, 2011; Zabransky, 2015). The methodological choices in the
construction of an index such as the component domains, the common metric
conversion, the weightings, and analytic approaches can have a signif‌icant impact
on the index outcomes (Jacobs, Goddard, & Smith, 2007; Paruolo, Saisana, &
Saltelli, 2013). An index result may leave little room for the recognition or
interpretation of changes. For example, a rise in one indicator could mask a fall in
another indicator and not affect the net index value (Ritter, 2009). The lack of
ability to make any nuanced interpretation of index values has led to reviewers
suggesting that indexes should be used in conjunction with a contextual analysis
to determine how sociocultural changes may bear on “harm” or “policy” (Rolles
& Measham, 2011).
Policy evaluation is the central concern of indexes: their utility is the extent to
which they can serve as a benchmarking or measurement tool to evaluate policy.
Previous categorizations of indexes in drug and alcohol and policy analysis more
broadly have identif‌ied two types of policy evaluation indexes: those that are
input-driven, and those that are output-driven (Sevigny & Saisana, 2013). Input-
driven indexes are concerned with combining multiple policy types (across laws,
regulations, and programs) and the associated implementation of those policies to
derive a composite index of policy. On the other hand, output-driven indexes are
concerned with measuring the consequences of policies, such as the health or
crime outcomes, again combining multiple indicators into one metric. There are
substantial challenges in developing either an input (policy) or an output (harm)
index, including the decisions around what to focus on (in our case, e.g., which
104 World Medical & Health Policy, 9:1

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT